CNTA· Centessa Pharmaceuticals Plc
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 8 | $9M |
Quarterly ownership history
Last 4 quarters
CNTA Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$6.1B
Enterprise value$6.0B
EV / EBITDA (TTM)-23.28
P/E ratio (TTM)—
Forward P/E-20.86
P/S ratioInfinity
P/B ratio12.57
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$209M
Free cash flow (TTM)-$131M
Total cash$277M
Total debt$118M
Debt / equity24.17
Current ratio9.53
Income Statement
Total revenue (TTM)$0
Revenue per share (TTM)0.00
Gross profit (TTM)$0
EBITDA (TTM)-$256M
Net income (TTM)-$251M
EPS diluted (TTM)-1.78
Shares outstanding154,728,966
Float shares97,958,908
Profitability
Gross margin0.00%
Operating margin0.00%
EBITDA margin0.00%
Net margin0.00%
Efficiency
Return on assets (TTM)-27.43%
Return on equity (TTM)-57.38%
Price History
Current price$39.59
52 Week high$40.26
52 Week low$10.95
50 day average$34.23
200 day average$25.75
Average volume (10 day)1,322,410
1-year beta—
1-year price target$44.57
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:36 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com